LISINOPRIL TABLETS 20 MG
LISINOPRIL (LISINOPRIL DIHYDRATE) : 20 MG · DIN 02554518 · SIVEM PHARMACEUTICALS ULC
Health Canada status: MARKETED
What is LISINOPRIL TABLETS?
LISINOPRIL TABLETS 20 MG contains LISINOPRIL (LISINOPRIL DIHYDRATE) : 20 MG. It is listed in the Health Canada Drug Product Database under DIN 02554518, held by SIVEM PHARMACEUTICALS ULC, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 29-Dec-2025. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02554518 |
|---|---|
| Brand name | LISINOPRIL TABLETS |
| Generic / active ingredient | LISINOPRIL (LISINOPRIL DIHYDRATE) : 20 MG |
| Manufacturer | SIVEM PHARMACEUTICALS ULC |
| Strength | 20 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | C09AA03 LISINOPRIL |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 29-Dec-2025 |
What can be used instead?
Other Canadian products sharing ATC code C09AA03 LISINOPRIL. 15 of 99 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| AURO-LISINOPRIL | 10 MG | TABLET | AURO PHARMA INC | MARKETED | DIN 02394480 |
| AURO-LISINOPRIL | 20 MG | TABLET | AURO PHARMA INC | MARKETED | DIN 02394499 |
| AURO-LISINOPRIL | 5 MG | TABLET | AURO PHARMA INC | MARKETED | DIN 02394472 |
| LISINOPRIL (TYPE Z) | 10 MG | TABLET | SANIS HEALTH INC | MARKETED | DIN 02525194 |
| LISINOPRIL (TYPE Z) | 20 MG | TABLET | SANIS HEALTH INC | MARKETED | DIN 02525208 |
| LISINOPRIL (TYPE Z) | 5 MG | TABLET | SANIS HEALTH INC | MARKETED | DIN 02525186 |
| LISINOPRIL TABLETS | 10 MG | TABLET | SIVEM PHARMACEUTICALS ULC | MARKETED | DIN 02554496 |
| LISINOPRIL TABLETS | 5 MG | TABLET | SIVEM PHARMACEUTICALS ULC | MARKETED | DIN 02554488 |
| TEVA-LISINOPRIL (TYPE Z) | 10 MG | TABLET | TEVA CANADA LIMITED | MARKETED | DIN 02285126 |
| TEVA-LISINOPRIL (TYPE Z) | 20 MG | TABLET | TEVA CANADA LIMITED | MARKETED | DIN 02285134 |
Who else supplies LISINOPRIL worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. LISINOPRIL appears in 493 registered pack listings across 14 markets, published on 11 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.